Literature DB >> 32190489

Successful Utilization of a Live Donor Kidney with Angiomyolipoma.

George Rofaiel1, Gilbert Pan1, Jeffrey Campsen1, Robin Kim1, Blake Hamilton2.   

Abstract

The gap between the kidney transplant recipient list and the number of organs available for transplantation continues to grow. Kidneys from living donors are a major source of high-quality organs. However, they commonly have benign conditions such as cysts and benign tumors that present as operative challenges. This case presents a donor kidney that had a benign angiomyolipoma. The kidney was donated in a standard, minimally invasive fashion. The tumor was then removed on the back table and transplanted without an issue. Both donor and recipient enjoyed a speedy recovery with no significant complications.
Copyright © 2020, Rofaiel et al.

Entities:  

Keywords:  angiomyolipoma; kidney transplantation; live donor kidneys

Year:  2020        PMID: 32190489      PMCID: PMC7067347          DOI: 10.7759/cureus.6937

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  13 in total

Review 1.  Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.

Authors:  Sergio Fernández-Pello; Milan Hora; Teele Kuusk; Rana Tahbaz; Saeed Dabestani; Yasmin Abu-Ghanem; Laurence Albiges; Rachel H Giles; Fabian Hofmann; Markus A Kuczyk; Thomas B Lam; Lorenzo Marconi; Axel S Merseburger; Thomas Powles; Michael Staehler; Alessandro Volpe; Börje Ljungberg; Axel Bex; Karim Bensalah
Journal:  Eur Urol Oncol       Date:  2019-06-04

2.  Deceased-donor characteristics and the survival benefit of kidney transplantation.

Authors:  Robert M Merion; Valarie B Ashby; Robert A Wolfe; Dale A Distant; Tempie E Hulbert-Shearon; Robert A Metzger; Akinlolu O Ojo; Friedrich K Port
Journal:  JAMA       Date:  2005-12-07       Impact factor: 56.272

Review 3.  Living Kidney Donation: Strategies to Increase the Donor Pool.

Authors:  Lung-Yi Lee; Thomas A Pham; Marc L Melcher
Journal:  Surg Clin North Am       Date:  2019-02       Impact factor: 2.741

4.  Outcome of Live-Donor Renal Transplants With Incidentally Diagnosed Renal Angiomyolipoma in the Donor.

Authors:  Mohamed H Zahran; Ahmed I Kamal; Ahmed Abdelfattah; Mohamed Elsayed Mashaly; Islam Fakhreldin; Yasser Osman; Bedeir Ali-El-Dein
Journal:  Transplant Proc       Date:  2019-06-27       Impact factor: 1.066

Review 5.  Renal angiomyolipoma: preoperative identification of atypical fat-poor AML.

Authors:  Crystal Farrell; Sabrina L Noyes; Mouafak Tourojman; Brian R Lane
Journal:  Curr Urol Rep       Date:  2015-03       Impact factor: 3.092

Review 6.  Update on the Diagnosis and Management of Renal Angiomyolipoma.

Authors:  Andrew S Flum; Nabeel Hamoui; Mohammed A Said; Ximing J Yang; David D Casalino; Barry B McGuire; Kent T Perry; Robert B Nadler
Journal:  J Urol       Date:  2015-11-21       Impact factor: 7.450

7.  The Outcomes of Living Kidney Donation from Medically Complex Donors: Implications for the Donor and the Recipient.

Authors:  Matthew Niemi; Didier A Mandelbrot
Journal:  Curr Transplant Rep       Date:  2014-03-01

8.  OPTN/SRTR 2018 Annual Data Report: Kidney.

Authors:  A Hart; J M Smith; M A Skeans; S K Gustafson; A R Wilk; S Castro; J Foutz; J L Wainright; J J Snyder; B L Kasiske; A K Israni
Journal:  Am J Transplant       Date:  2020-01       Impact factor: 8.086

Review 9.  The Risks of Renal Angiomyolipoma: Reviewing the Evidence.

Authors:  Raouf M Seyam; Waleed K Alkhudair; Said A Kattan; Mohamed F Alotaibi; Hassan M Alzahrani; Waleed M Altaweel
Journal:  J Kidney Cancer VHL       Date:  2017-10-16

10.  Management of Bilateral Ureteral Obstruction After Transplantation of Pediatric En Bloc Kidneys, a Case Report and Review of Available Literature.

Authors:  Sridhar R Allam; Ikponmwosa Iyamu; Gilbert Pan; Eryberto Martinez; Balamurugan Sankarapandian; Sameh Fayek; George Rofaiel
Journal:  Transplant Direct       Date:  2019-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.